Joy M. Beveridge

441 total citations
10 papers, 168 citations indexed

About

Joy M. Beveridge is a scholar working on Immunology, Oncology and Economics and Econometrics. According to data from OpenAlex, Joy M. Beveridge has authored 10 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Oncology and 3 papers in Economics and Econometrics. Recurrent topics in Joy M. Beveridge's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Primary Care and Health Outcomes (2 papers) and Health Policy Implementation Science (2 papers). Joy M. Beveridge is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Primary Care and Health Outcomes (2 papers) and Health Policy Implementation Science (2 papers). Joy M. Beveridge collaborates with scholars based in United States and Australia. Joy M. Beveridge's co-authors include Steven B. Clauser, Arnold D. Kaluzny, Mary L. Fennell, Mario Sznol, DL Longo, Martin B Van Der Weyden, W J Urba, Thelma M. Watson, J. A. Charlesworth and Bruce A. Pussell and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Archives of Disease in Childhood.

In The Last Decade

Joy M. Beveridge

10 papers receiving 143 citations

Peers

Countries citing papers authored by Joy M. Beveridge

Since Specialization

Citations

This map shows the geographic impact of Joy M. Beveridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy M. Beveridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy M. Beveridge more than expected).

Fields of papers citing papers by Joy M. Beveridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy M. Beveridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy M. Beveridge. The network helps show where Joy M. Beveridge may publish in the future.

Co-authorship network of co-authors of Joy M. Beveridge

This figure shows the co-authorship network connecting the top 25 collaborators of Joy M. Beveridge. A scholar is included among the top collaborators of Joy M. Beveridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy M. Beveridge. Joy M. Beveridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Improving Cancer Care & Expanding Research in Community Hospitals 2011 ·Oncology Issues ·(unknown), Steven B. Clauser, (unknown), Joy M. Beveridge, Arnold D. Kaluzny	5
2	Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program 2009 ·Implementation Science ·Steven B. Clauser, (unknown), (unknown), Joy M. Beveridge, Mary L. Fennell, Arnold D. Kaluzny	39
3	Improving Clinical Research and Cancer Care Delivery in Community Settings: Evaluating the NCI Community Cancer Centers Program 2009 ·SSRN Electronic Journal ·Steven B. Clauser, (unknown), (unknown), Joy M. Beveridge, Mary L. Fennell, Arnold D. Kaluzny	2
4	Translating Scientific Advances into the Community Setting 2009 ·Oncology Issues ·(unknown), Steven B. Clauser, Joy M. Beveridge, (unknown)	20
5	Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma 1992 ·JNCI Journal of the National Cancer Institute ·Mario Sznol, J. W. Clark, John W. Smith, Ronald G. Steis, Walter J. Urba, Larry Rubinstein, (unknown), John E. Janik, William H. Sharfman, R. G. Fenton, Stephen P. Creekmore, (unknown), Kelly Conlon, James Hersey, Joy M. Beveridge, DL Longo	26
6	Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study. 1992 ·PubMed ·Mario Sznol, Ronald G. Steis, J. W. Smith, John E. Janik, William H. Sharfman, Walter J. Urba, R. G. Fenton, Stephen P. Creekmore, Joy M. Beveridge, Dario Livio Longo	5
7	Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a. 1991 ·Blood ·(unknown), DL Longo, W J Urba, (unknown), Thelma M. Watson, Joy M. Beveridge, (unknown), Mario Sznol, (unknown), (unknown)	36
8	Positioning to win : planning and executing the superior proposal 1982 ·Joy M. Beveridge, (unknown)	1
9	Severe combined immunodeficiency and adenosine deaminase deficiency: failure of enzyme replacement therapy. 1980 ·Archives of Disease in Childhood ·(unknown), (unknown), Martin B Van Der Weyden, (unknown), Joy M. Beveridge	19
10	Measles infection. Involvement of the complement system. 1976 ·PubMed ·J. A. Charlesworth, Bruce A. Pussell, L. P. Roy, (unknown), Joy M. Beveridge	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact